- Home
- ELVN vs PWP Comparison
ELVN vs PWP Comparison
Compare ELVN & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PWP
- Stock Information
- Founded
- ELVN 2016
- PWP 2006
- Country
- ELVN United States
- PWP United States
- Employees
- ELVN N/A
- PWP N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PWP Finance: Consumer Services
- Sector
- ELVN Health Care
- PWP Finance
- Exchange
- ELVN Nasdaq
- PWP Nasdaq
- Market Cap
- ELVN 1.2B
- PWP 1.3B
- IPO Year
- ELVN 2020
- PWP N/A
- Fundamental
- Price
- ELVN $19.02
- PWP $22.16
- Analyst Decision
- ELVN Strong Buy
- PWP Hold
- Analyst Count
- ELVN 5
- PWP 3
- Target Price
- ELVN $41.20
- PWP $23.67
- AVG Volume (30 Days)
- ELVN 489.5K
- PWP 1.1M
- Earning Date
- ELVN 11-12-2025
- PWP 11-07-2025
- Dividend Yield
- ELVN N/A
- PWP 1.24%
- EPS Growth
- ELVN N/A
- PWP N/A
- EPS
- ELVN N/A
- PWP 0.90
- Revenue
- ELVN N/A
- PWP $871,012,000.00
- Revenue This Year
- ELVN N/A
- PWP $1.99
- Revenue Next Year
- ELVN $20.05
- PWP $25.18
- P/E Ratio
- ELVN N/A
- PWP $25.08
- Revenue Growth
- ELVN N/A
- PWP 20.01
- 52 Week Low
- ELVN $13.30
- PWP $14.12
- 52 Week High
- ELVN $30.03
- PWP $27.03
- Technical
- Relative Strength Index (RSI)
- ELVN 44.06
- PWP 53.23
- Support Level
- ELVN $18.01
- PWP $21.56
- Resistance Level
- ELVN $20.30
- PWP $22.75
- Average True Range (ATR)
- ELVN 1.11
- PWP 0.81
- MACD
- ELVN -0.16
- PWP -0.05
- Stochastic Oscillator
- ELVN 30.70
- PWP 67.30
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PWP Perella Weinberg Partners
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.